Coenzyme F420

Identification

Generic Name
Coenzyme F420
DrugBank Accession Number
DB03913
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 773.5926
Monoisotopic: 773.179295885
Chemical Formula
C29H36N5O18P
Synonyms
  • Coenzyme F(420)
  • coenzyme γ-F420-2
  • F420
  • Factor F420
  • N-{N-[O-(7,8-didemethyl-8-hydroxy-5-deazariboflavin phospho)-(S)-lactyl]-γ-L-glutamyl}-L-glutamate

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
Dipeptides
Alternative Parents
Gamma-glutamyl amino acids / Glutamic acid and derivatives / Glutamine and derivatives / N-acyl-L-alpha-amino acids / Pyrido[2,3-d]pyrimidines / Quinolines and derivatives / Tricarboxylic acids and derivatives / Phosphoethanolamines / 1-hydroxy-2-unsubstituted benzenoids / Pyrimidones
show 16 more
Substituents
1-hydroxy-2-unsubstituted benzenoid / Alcohol / Alkyl phosphate / Alpha-amino acid or derivatives / Alpha-dipeptide / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Carbonyl group / Carboxamide group
show 35 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
ribitol phosphate, pyrimidoquinolines (CHEBI:16848)
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
64885-97-8
InChI Key
GEHSZWRGPHDXJO-NALJQGANSA-N
InChI
InChI=1S/C29H36N5O18P/c1-12(25(42)31-17(28(46)47)4-6-21(38)30-16(27(44)45)5-7-22(39)40)52-53(49,50)51-11-20(37)23(41)19(36)10-34-18-9-14(35)3-2-13(18)8-15-24(34)32-29(48)33-26(15)43/h2-3,8-9,12,16-17,19-20,23,35-37,41H,4-7,10-11H2,1H3,(H,30,38)(H,31,42)(H,39,40)(H,44,45)(H,46,47)(H,49,50)(H,33,43,48)/t12-,16-,17-,19-,20+,23-/m0/s1
IUPAC Name
(2S)-2-[(4S)-4-carboxy-4-[(2S)-2-{[hydroxy({[(2R,3S,4S)-2,3,4-trihydroxy-5-{8-hydroxy-2,4-dioxo-2H,3H,4H,10H-pyrimido[4,5-b]quinolin-10-yl}pentyl]oxy})phosphoryl]oxy}propanamido]butanamido]pentanedioic acid
SMILES
C[C@H](OP(O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=CC(O)=CC=C2C=C2C(=O)NC(=O)N=C12)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O

References

General References
Not Available
KEGG Compound
C00876
PubChem Compound
123996
PubChem Substance
46504684
ChemSpider
16743965
ChEBI
16848
ZINC
ZINC000198210272
PDBe Ligand
F42
Wikipedia
Coenzyme_F420
PDB Entries
1jay / 1rhc / 1z69 / 3b4y / 3iqe / 3r5r / 3r5w / 3r5y / 3r5z / 3zfs
show 4 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-3.7Chemaxon
pKa (Strongest Acidic)1.78Chemaxon
pKa (Strongest Basic)-6Chemaxon
Physiological Charge-5Chemaxon
Hydrogen Acceptor Count18Chemaxon
Hydrogen Donor Count11Chemaxon
Polar Surface Area368.55 Å2Chemaxon
Rotatable Bond Count20Chemaxon
Refractivity170.88 m3·mol-1Chemaxon
Polarizability70.9 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption-0.922
Blood Brain Barrier-0.7181
Caco-2 permeable-0.7238
P-glycoprotein substrateSubstrate0.6912
P-glycoprotein inhibitor INon-inhibitor0.7088
P-glycoprotein inhibitor IINon-inhibitor0.9664
Renal organic cation transporterNon-inhibitor0.8785
CYP450 2C9 substrateNon-substrate0.6951
CYP450 2D6 substrateNon-substrate0.821
CYP450 3A4 substrateSubstrate0.5444
CYP450 1A2 substrateNon-inhibitor0.7751
CYP450 2C9 inhibitorNon-inhibitor0.7855
CYP450 2D6 inhibitorNon-inhibitor0.8721
CYP450 2C19 inhibitorNon-inhibitor0.728
CYP450 3A4 inhibitorNon-inhibitor0.697
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7138
Ames testNon AMES toxic0.6609
CarcinogenicityNon-carcinogens0.9044
BiodegradationNot ready biodegradable0.7725
Rat acute toxicity2.4869 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8645
hERG inhibition (predictor II)Inhibitor0.5942
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-05di-0246201900-27107f5488b7ec710c3c
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0w90-0000201900-42287bcfcfbf5a81c916
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-6940210300-92ae00f63b951ccfc039
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-00mk-0930023100-450c6e5af043998e1934
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-00lr-0910000000-322eaecda55d0e58384d
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-9500702400-b28092f30baba46bf55a
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-235.23616
predicted
DeepCCS 1.0 (2019)
[M+H]+236.97462
predicted
DeepCCS 1.0 (2019)
[M+Na]+243.28883
predicted
DeepCCS 1.0 (2019)

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52